Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 105514
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.105514
Table 3 Multivariate prediction of type 2 diabetes remission 1-year after esophagectomy with gastric conduit reconstruction
Variables
Univariable logistic regression analysis, P value
Univariable logistic regression analysis, OR
Multivariable logistic regression analysis, P value
Multivariable logistic regression analysis, OR
Age, years0.0030.899 (0.837-0.965)0.0160.910 (0.844-0.982)
Sex0.2060.518 (0.187-1.437)
Histology type, squamous cell carcinoma vs others0.3380.479 (0.106-2.162)
Pathology stage, I/II vs III/IV0.9061.054 (0.442-2.512)
Neoadjuvant therapy0.6060.786 (0.315-1.963)
Surgery procedure, McKeown vs trans-hiatal0.2770.569 (0.206-1.570)
Anastomosis leak0.9671.034 (0.220-4.859)
Adjuvant therapy0.8880.940 (0.399-2.216)
Duration of T2D0.0090.825 (0.714-0.953)0.0620.866 (0.745-1.008)
Fasting glucose before surgery, mmol/L0.378 1.103 (0.887-1.371)
HbA1c before surgery (%)0.0111.460 (1.090-1.958)0.0801.365 (0.964-1.933)
Insulin treatment vs without0.950 1.037 (0.329-3.269)
Body weight before surgery, kg0.0011.082 (1.032-1.134)0.0221.084 (1.012-1.162)
BMI, kg/m20.0131.212 (1.042-1.410)0.8851.018 (0.799-1.298)